Interleukin-1 and Ischemic Brain Injury in the Newborn: Development of a Small Molecule Inhibitor of IL-1 Receptor

Seminars in Perinatology

Volumn 32, Issue 5, 2008, Pages 325-333

  Quiniou, Christiane ^a   Kooli, Emna ^b   Joyal, Jean Sébastien ^a   Sapieha, Przemyslaw ^a   Sennlaub, Florian ^c   Lahaie, Isabelle ^a   Shao, Zhuo ^a,b   Hou, Xin ^a   Hardy, Pierre ^a   Lubell, William ^d   Chemtob, Sylvain ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c INSERM   (France)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RYTVELA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING SITE; BRAIN INJURY; BRAIN ISCHEMIA; CONCENTRATION (PARAMETERS); CONTINUOUS INFUSION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; ENCEPHALITIS; ENTERITIS; EXCITOTOXICITY; HUMAN; MICROVASCULARIZATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; UNSPECIFIED SIDE EFFECT;

EID: 53149130253     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2008.07.001     Document Type: Article

References (35)

1. McLean C., and Ferriero D. Mechanisms of hypoxic-ischemic injury in the term infant. Sem Perinatol 28 (2004) 425-432
2. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 (1988) 623-634
3. Beckman J.S., Viera L., Estévez A.G., et al. Nitric oxide and peroxynitrite in the perinatal period. Semin Perinatol 24 (2000) 37-41
4. Ferriero D.M., Holtzman D.M., Black S.M., et al. Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. Neurobiol Dis 3 (1996) 64-71
5. Sun G.Y., Horrocks L.A., and Farooqui A.A. The roles of NADPH oxidase and phospholipases A2 in oxidative and inflammatory responses in neurodegenerative diseases. J Neurochem 103 (2007) 1-16
6. Buonocore G., Perrone S., and Bracci R. Free radicals and brain damage in the newborn. Biol Neonate 79 (2001) 180-186
7. Ferriero D.M. Oxidant mechanisms in neonatal hypoxia-ischemia. Dev Neurosci 23 (2001) 198-202
8. Chew L.J., Takanohashi A., and Bell M. Microglia and inflammation: impact on developmental brain injuries. Ment Retard Dev Disabil Res Rev 12 (2006) 105-112
9. Barone F.C., and Feuerstein G.Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 19 (1999) 819-834
10. Hedtjarn M., Mallard C., Arvidsson P., et al. White matter injury in the immature brain: role of interleukin-18. Neurosci Lett 373 (2005) 16-20
11. Lucas S.M., Rothwell N.J., and Gibson R.M. The role of inflammation in CNS injury and disease. Br J Pharmacol 147 (2006) S232-S240
12. Wu YW, Colford JM Jr: Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 284:1417-1424, 200
13. Dammann O., and Leviton A. Role of the fetus in perinatal infection and neonatal brain damage. Curr Opin Pediatr 12 (2000) 99-104
14. Kadhim H., Tabarki B., Verellen G., et al. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 56 (2001) 1278-1284
15. Arnett H.A., Mason J., Marino M., et al. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4 (2001) 1116-1122
16. Loddick S.A., Turnbull A.V., and Rothwell N.J. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 18 (1998) 176-179
17. Martin D., Chinookoswong N., Miller G., et al. The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia. Exp Neurol 130 (1994) 362-367
18. Dinarello C.A., Gatti S., and Bartfai T. Fever: links with an ancient receptor. Curr Biol 9 (1999) R147-R150
19. Arend W.P. Interleukin-1 receptor antagonist. Adv Immunol 54 (1993) 167-227
20. Zhou N., Luo Z., and Luo J. Exploring the stereochemistry of CXCR4-peptide recognition and inhibiting HIV-1 entry with D-peptides derived from chemokines. J Biol Chem 277 (2002) 17476-17485
21. McDonnell J.M., Beavil A.J., and Mackay G.A. Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor. Nat Struct Biol 3 (1996) 419-426
22. Quiniou C., Sapieha P., Lahaie I., et al. Development of a novel non-competitive antagonist of Interleukin-1 receptor. J Immunol 180 (2008) 6977-6987
23. Kenakin T. New concepts in drug discovery: collateral efficacy and permissive antagonism. Nat Rev Drug Discov 4 (2005) 919-927
24. Koshland D.E. Conformational changes: how small is big enough?. Nat Med 4 (1998) 1112-1114
25. Kenakin T. Allosteric modulators: the new generation of receptor antagonist. Mol Interv 4 (2004) 222-229
26. Gardiner S.M., Kemp P.A., and March J.E. The influence of antibodies to TNF-alpha and IL-1beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats. Br J Pharmacol 125 (1998) 1543-1550
27. Rogler G., and Andus T. Cytokines in inflammatory bowel disease. World J Surg 22 (1998) 382-389
28. Galvez J., Garrido M., Rodríguez-Cabezas M.E., et al. The intestinal anti-inflammatory activity of UR-12746S on reactivated experimental colitis is mediated through downregulation of cytokine production. Inflamm Bowel Dis 9 (2003) 363-371
29. Peterson T.C., Cleary C.E., and Shaw A.M. Therapeutic role for bismuth compounds in TNBS-induced colitis in the rat. Dig Dis Sci 45 (2000) 466-473
30. Ljungqvist A., Feng D.M., Hook W., et al. Antide and related antagonists of luteinizing hormone release with long action and oral activity. Proc Natl Acad Sci USA 85 (1988) 8236-8240
31. Bae J.H., Oh M.M., and Shim K.S. The effects of long-term administration of oral desmopressin on the baseline secretion of antidiuretic hormone and serum sodium concentration for the treatment of nocturia: a circadian study. J Urol 178 (2007) 200-203
32. Rice III J.E., Vannucci R.C., and Brierley J.B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 9 (1981) 131-141
33. Hardy P., Dumont I., Bhattacharya M., et al. Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy. Cardiovasc Res 47 (2000) 489-509
34. Sirinyan M., Sennlaub F., Dorfman A., et al. Hyperoxic exposure leads to nitrative stress and ensuing microvascular degeneration and diminished brain mass and function in the immature subject. Stroke 37 (2006) 2807-2815
35. Edwards A.D., and Tan S. Perinatal infections, prematurity and brain injury. Curr Opin Pediatr 18 (2006) 119-124